Pels, Salley

Pels, Salley was paid $509K by Medicaid between Jan 2020 and Aug 2024, across 15 billing codes. Its largest line is J1745, Injection, infliximab, excludes biosimilar, 10 mg — 85% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	1,044	$473K
2021	478	$16K
2022	163	$6K
2023	69	$3K
2024incomplete	245	$11K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J1745	Injection, infliximab, excludes biosimilar, 10 mg	85%	94	90	$434K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	4.3%	143	133	$22K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.1%	155	144	$21K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.1%	575	529	$11K
82728		1.6%	266	235	$8K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	50	47	$4K
85045		<1%	279	248	$3K
80076		<1%	110	106	$2K
83550		<1%	55	54	$1K
86140		<1%	84	81	$991.25
85651		<1%	116	112	$939.55
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	12	12	$809.40

3 more codes

85027		<1%	14	$212.87
36415	Collection of venous blood by venipuncture	<1%	18	$87.09
J7050	Infusion, normal saline solution, 250 cc	<1%	28	$13.16

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.